InsiderClue
← All stocks

Tarsus Pharmaceuticals, Inc.

TARS Net selling
CIK 0001819790 #1728 in the set updated 22 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$20.29M
$12.03M on a plan · $979.74K straight out of an exercise
Sold at will
$7.28M
23 of 60 sales
Net
−$20.29M
−$7.28M against sales at will

By person

14 insiders · 60 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Azamian Bobak R.
President/CEO and Board Chair
—
$5.51M (11) scheduled
−$5.51M
1,709,403
3.90%
$136.77M
−2.7%
LINK WILLIAM J PHD
Director
—
$4.48M (13) scheduled
−$4.48M
94,487
0.2153%
$7.56M
−46.8%
Whitfield Dianne C.
Chief Human Resources Officer
—
$2.69M (8) scheduled
−$2.69M
35,028
0.0798%
$2.80M
+2.5%
Lin Elizabeth Yeu
Chief Medical Officer
—
$2.36M (11) scheduled
−$2.36M
16,177
0.0369%
$1.29M
−51.4%
Neervannan Seshadri
Chief Operating Officer
—
$2.00M (6) scheduled
−$2.00M
79,482
0.1811%
$6.36M
+18.2%
Farrow Jeffrey S
See Remarks
—
$1.32M (4)
−$1.32M
56,801
0.1294%
$4.54M
+213.2%
Mottiwala Aziz
Chief Commercial Officer
—
$892.53K (3)
−$892.53K
61,480
0.1401%
$4.92M
+11.5%
Wahl Bryan
General Counsel
—
$850.42K (3)
−$850.42K
63,959
0.1457%
$5.12M
+50.0%
Goodrich Katherine
Director
—
$183.38K (1) scheduled
−$183.38K
2,233
0.0051%
$178.66K
—
Goldberg Andrew D.
Director
—
—
—
19,654
0.0448%
$1.57M
+209.5%
YARNO WENDY L
Director
—
—
—
16,956
0.0386%
$1.36M
+63.8%
CHAUDHURI BHASKAR
Director
—
—
—
11,654
0.0266%
$932.44K
+117.8%
PYOTT DAVID E I
Director
—
—
—
10,958
0.0250%
$876.75K
+16.9%
Morrison Scott W
Director
—
—
—
7,638
0.0174%
$611.12K
+27.0%

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
Farrow Jeffrey S
16 Jun 2026
See Remarks
Sell
14,396
$60.95
$877.44K
Azamian Bobak R.
19 Mar 2026
President/CEO and Board Chair
Sell
11,964
$67.00
$801.59K
Farrow Jeffrey S
19 Mar 2026
See Remarks
Sell
2,186
$67.00
$146.46K
Lin Elizabeth Yeu
19 Mar 2026
Chief Medical Officer
Sell
390
$67.00
$26.13K
Mottiwala Aziz
19 Mar 2026
Chief Commercial Officer
Sell
4,440
$67.00
$297.48K
Neervannan Seshadri
19 Mar 2026
Chief Operating Officer
Sell
4,589
$67.00
$307.46K
Wahl Bryan
19 Mar 2026
General Counsel
Sell
4,231
$67.00
$283.48K
Whitfield Dianne C.
19 Mar 2026
Chief Human Resources Officer
Sell
4,174
$67.00
$279.66K
Azamian Bobak R.
18 Mar 2026
President/CEO and Board Chair
Sell
11,667
$68.71
$801.64K
Farrow Jeffrey S
18 Mar 2026
See Remarks
Sell
2,133
$68.71
$146.56K
Lin Elizabeth Yeu
18 Mar 2026
Chief Medical Officer
Sell
379
$68.71
$26.04K
Mottiwala Aziz
18 Mar 2026
Chief Commercial Officer
Sell
4,330
$68.71
$297.51K
Neervannan Seshadri
18 Mar 2026
Chief Operating Officer
Sell
3,610
$68.71
$248.04K
Wahl Bryan
18 Mar 2026
General Counsel
Sell
4,125
$68.71
$283.43K
Whitfield Dianne C.
18 Mar 2026
Chief Human Resources Officer
Sell
4,071
$68.71
$279.72K
Azamian Bobak R.
17 Mar 2026
President/CEO and Board Chair
Sell
10,972
$69.42
$761.68K
Farrow Jeffrey S
17 Mar 2026
See Remarks
Sell
2,111
$69.42
$146.55K
Lin Elizabeth Yeu
17 Mar 2026
Chief Medical Officer
Sell
375
$69.42
$26.03K
Mottiwala Aziz
17 Mar 2026
Chief Commercial Officer
Sell
4,286
$69.42
$297.53K
Neervannan Seshadri
17 Mar 2026
Chief Operating Officer
Sell
3,125
$69.42
$216.94K
Wahl Bryan
17 Mar 2026
General Counsel
Sell
4,084
$69.42
$283.51K
Whitfield Dianne C.
17 Mar 2026
Chief Human Resources Officer
Sell
4,029
$69.42
$279.69K
Lin Elizabeth Yeu
16 Dec 2025
Chief Medical Officer
Sell
2,078
$79.50
$165.20K
Show all 60 transactions →

What was left out

Form 4 filings counted 60
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 34
Sales straight out of an exercise 3
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 292,795
History held since 20 Oct 2020